Banibrata Das

发表

Synthesis, photophysical and electrochemical properties of perfluoroisopropyl substituted binuclear phthalocyanine conjugated with a butadiyne linker

N. Shibata, Shuichi Nakamura, Banibrata Das, 2009 .

Trifluoroethoxy-coating improves the axial ligand substitution of subphthalocyanine.

Etsuko Tokunaga, N. Shibata, M. Shiro, 2010, Chemistry.

Solubility of trifluoroethoxyphthalocyanines and -subphthalocyanines in liquid and supercritical carbon dioxide

Etsuko Tokunaga, N. Shibata, N. Kobayashi, 2010 .

A Novel Iron(II) Preferring Dopamine Agonist Chelator as Potential Symptomatic and Neuroprotective Therapeutic Agent for Parkinson's Disease.

M. Reith, T. Stemmler, Aloke K. Dutta, 2017, ACS chemical neuroscience.

Dopamine D 3 Agonists in the Treatment of Parkinson's Disease

Aloke K. Dutta, Gyan Modi, Banibrata Das, 2015 .

Dopamine D3 agonists in the treatment of Parkinson's disease.

Aloke K. Dutta, Gyan Modi, Banibrata Das, 2015, Current topics in medicinal chemistry.

Bivalent dopamine agonists with co-operative binding and functional activities at dopamine D2 receptors, modulate aggregation and toxicity of alpha synuclein protein.

M. Reith, Aloke K. Dutta, Tamara Antonio, 2022, Bioorganic & medicinal chemistry.

Perfluoroisopropyl Zinc Phthalocyanines Conjugated with Deoxyribonucleosides: Synthesis, Photophysical Properties and In Vitro Photodynamic Activities

Takuma Sasaki, Etsuko Tokunaga, N. Shibata, 2010 .

Design, Synthesis, and Pharmacological Characterization of Carbazole Based Dopamine Agonists as Potential Symptomatic and Neuroprotective Therapeutic Agents for Parkinson's Disease.

M. Reith, Aloke K. Dutta, Liping Xu, 2018, ACS chemical neuroscience.

D‐512, a novel dopamine D2/3 receptor agonist, demonstrates greater anti‐Parkinsonian efficacy than ropinirole in Parkinsonian rats

Banibrata Das, D. Lindenbach, C. Bishop, 2017, British journal of pharmacology.

A novel iron (II) preferring dopamine agonist chelator D-607 significantly suppresses α-syn- and MPTP-induced toxicities in vivo

J. Andersen, Aloke K. Dutta, Subramanian Rajagopalan, 2017, Neuropharmacology.

D-685 Reverses Motor Deficits and Reduces Accumulation of Human α-Synuclein Protein in Two Different Parkinson's Disease Animal Models.

R. Rissman, B. Spencer, Aloke K. Dutta, 2023, ACS chemical neuroscience.

Development of a Highly Potent D2/D3 Agonist and a Partial Agonist from Structure-Activity Relationship Study of N(6)-(2-(4-(1H-Indol-5-yl)piperazin-1-yl)ethyl)-N(6)-propyl-4,5,6,7-tetrahydrobenzo[d]thiazole-2,6-diamine Analogues: Implication in the Treatment of Parkinson's Disease.

M. Reith, Aloke K. Dutta, Tamara Antonio, 2015, Journal of medicinal chemistry.

Synthesis of Benzene-centered Trinuclear Phthalocyanines by Triple-click Chemistry

Etsuko Tokunaga, N. Shibata, Banibrata Das, 2010 .

D-578, an orally active triple monoamine reuptake inhibitor, displays antidepressant and anti-PTSD effects in rats.

M. Reith, S. Perrine, Liping Xu, 2019, European journal of pharmacology.